Charter Oak Capital Management, LLC Bristol Myers Squibb CO Transaction History

Charter Oak Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $24,653 - $29,561	401 Added 12.9%	3,509 $256,000
Q4 2021 Feb 09, 2022	BUY	$53.63 - $62.52 $3,325 - $3,876	62 Added 2.04%	3,108 $194,000
Q2 2021 Jul 29, 2021	SELL	$61.91 - $67.42 $6,067 - $6,607	-98 Reduced 3.12%	3,046 $204,000
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $12,105 - $13,614	-204 Reduced 6.09%	3,144 $198,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $193,313 - $219,059	3,348 New	3,348 $208,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Charter Oak Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Charter Oak Capital Management, LLC with notifications on news.